Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin and Tolterodine for Double J Stent-Related Urinary Symptoms
IRCT20160924029935N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of terazosin and tolterodine in Micturition disorder and ureterolithiasis, sponsored by Mashhad University of Medical Sciences. Started Mar 2019; status: completed.
02
Drugs
terazosintolterodine
03
Conditions
Micturition disorderureterolithiasis
Beyond the preview
Go deeper on IRCT20160924029935N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160924029935N2.